148 related articles for article (PubMed ID: 28652546)
1. Clinical application of ghrelin for diabetic peripheral neuropathy.
Ueno H; Shiiya T; Nagamine K; Tsuchimochi W; Sakoda H; Shiomi K; Kangawa K; Nakazato M
Endocr J; 2017; 64(Suppl.):S53-S57. PubMed ID: 28652546
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of TGF-β1 in patients of diabetic peripheral neuropathy and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S135-9. PubMed ID: 26559756
[TBL] [Abstract][Full Text] [Related]
3. Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial.
Chuar PF; Ng YT; Phang SCW; Koay YY; Ho JI; Ho LS; Botross Henien NP; Ahmad B; Abdul Kadir K
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836025
[TBL] [Abstract][Full Text] [Related]
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
[TBL] [Abstract][Full Text] [Related]
5. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of TNF-α in peripheral neuropathy patients and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2013; 7(4):238-42. PubMed ID: 24290092
[TBL] [Abstract][Full Text] [Related]
7. Ratio of motor nerve conduction velocity to F-wave conduction velocity in diabetic neuropathy.
Ohgaki K; Nakano K; Shigeta H; Kitagawa Y; Nakamura N; Iwamoto K; Makino M; Takanashi Y; Kajiyama S; Kondo M
Diabetes Care; 1998 Apr; 21(4):615-8. PubMed ID: 9571352
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plasma levels of adrenomedullin and ghrelin, and their correlation with electrophysiological changes in diabetic neuropathy.
Zakareia FA
Neurosciences (Riyadh); 2012 Oct; 17(4):327-35. PubMed ID: 23022897
[TBL] [Abstract][Full Text] [Related]
9. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
[TBL] [Abstract][Full Text] [Related]
10. The Therapeutic Effect of Pancreatic Kininogenase on Treatment of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes.
Jin YP; Su XF; Li HQ; Wu JD; Ding B; Sun R; Shan T; Ye L; Ma JH
Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):618-621. PubMed ID: 27701714
[No Abstract] [Full Text] [Related]
11. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
[TBL] [Abstract][Full Text] [Related]
12. Effect of aerobic exercise on peripheral nerve functions of population with diabetic peripheral neuropathy in type 2 diabetes: a single blind, parallel group randomized controlled trial.
Dixit S; Maiya AG; Shastry BA
J Diabetes Complications; 2014; 28(3):332-9. PubMed ID: 24507164
[TBL] [Abstract][Full Text] [Related]
13. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial.
Heydari M; Homayouni K; Hashempur MH; Shams M
J Diabetes; 2016 Mar; 8(2):246-52. PubMed ID: 25800045
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes.
Ekberg K; Brismar T; Johansson BL; Jonsson B; Lindström P; Wahren J
Diabetes; 2003 Feb; 52(2):536-41. PubMed ID: 12540632
[TBL] [Abstract][Full Text] [Related]
15. Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy.
Vinik AI; Bril V; Litchy WJ; Price KL; Bastyr EJ;
Muscle Nerve; 2005 Nov; 32(5):619-25. PubMed ID: 16116628
[TBL] [Abstract][Full Text] [Related]
16. Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy.
Tesfaye S; Harris ND; Wilson RM; Ward JD
Diabetologia; 1992 Feb; 35(2):155-9. PubMed ID: 1547920
[TBL] [Abstract][Full Text] [Related]
17. ACUDIN - ACUpuncture and laser acupuncture for treatment of DIabetic peripheral Neuropathy: a randomized, placebo-controlled, partially double-blinded trial.
Meyer-Hamme G; Friedemann T; Greten HJ; Plaetke R; Gerloff C; Schroeder S
BMC Neurol; 2018 Apr; 18(1):40. PubMed ID: 29653569
[TBL] [Abstract][Full Text] [Related]
18. Comparison of diabetic neuropathy symptom score and medial plantar sensory nerve conduction studies in diabetic patients showing normal routine nerve conduction studies.
An JY; Park MS; Kim JS; Shon YM; Lee SJ; Kim YI; Lee KS; Kim BJ
Intern Med; 2008; 47(15):1395-8. PubMed ID: 18670144
[TBL] [Abstract][Full Text] [Related]
19. Possible contribution of adipocytokines on diabetic neuropathy.
Matsuda M; Kawasaki F; Inoue H; Kanda Y; Yamada K; Harada Y; Saito M; Eto M; Matsuki M; Kaku K
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S121-3. PubMed ID: 15563961
[TBL] [Abstract][Full Text] [Related]
20. [Systematic review and Meta-analysis of efficacy and safety of Shuxuetong Injection in treatment of diabetic peripheral neuropathy].
Li X; Li B; Wang TY; Wang H; Li Q
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(11):3088-3094. PubMed ID: 35718533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
